Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
Garfield
David H
DH
Hercbergs
Aleck
A
Davis
Paul J
PJ
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D020249:Hormone Replacement Therapy; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced / Q000188:drug therapy*; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D011758:Pyrroles / Q000008:administration & dosage / Q000009:adverse effects*; D000077210:Sunitinib; D013963:Thyroid Hormones / Q000008:administration & dosage* / Q000009:adverse effects
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D013963:Thyroid Hormones; D000077210:Sunitinib